Neuropace (NPCE) had the highest return between January 1, 2023 and March 31, 2023 by a US stock with a market cap of $300M to $2B or a market cap of $10B+, returning 236.2%.
| ASSET | DATE | % RETURN |
|---|---|---|
Neuropace (NPCE) | 1/1/2023 - 3/31/2023 | 236.23% |
Innodata (INOD) | 1/1/2023 - 3/31/2023 | 177.27% |
American Coastal Insurance (ACIC) | 1/1/2023 - 3/31/2023 | 158.69% |
NGL Energy Partners (NGL) | 1/1/2023 - 3/31/2023 | 152.17% |
Bit Digital (BTBT) | 1/1/2023 - 3/31/2023 | 148.39% |
Sky Harbour (SKYH) | 1/1/2023 - 3/31/2023 | 145.39% |
IREN (IREN) | 1/1/2023 - 3/31/2023 | 133.59% |
American Battery Technology Company Common Stock (ABAT) | 1/1/2023 - 3/31/2023 | 127.6% |
Sophia Genetics (SOPH) | 1/1/2023 - 3/31/2023 | 126.94% |
Bitfarms (BITF) | 1/1/2023 - 3/31/2023 | 122.48% |
HIVE Blockchain Technologies (HIVE) | 1/1/2023 - 3/31/2023 | 120.81% |
BridgeBio Pharma (BBIO) | 1/1/2023 - 3/31/2023 | 113.11% |
Fastly, Inc Class A Common Stock (FSLY) | 1/1/2023 - 3/31/2023 | 112.19% |
Tyra Biosciences (TYRA) | 1/1/2023 - 3/31/2023 | 107.89% |
Dianthus Therapeutics (DNTH) | 1/1/2023 - 3/31/2023 | 104.82% |
Navitas Semiconductor (NVTS) | 1/1/2023 - 3/31/2023 | 103.62% |
Carvana (CVNA) | 1/1/2023 - 3/31/2023 | 103.53% |
MoonLake Immunotherapeutics (MLTX) | 1/1/2023 - 3/31/2023 | 101.79% |
Immuneering (IMRX) | 1/1/2023 - 3/31/2023 | 101.04% |
MicroStrategy (MSTR) | 1/1/2023 - 3/31/2023 | 100.67% |
Daktronics (DAKT) | 1/1/2023 - 3/31/2023 | 98.25% |
Omeros (OMER) | 1/1/2023 - 3/31/2023 | 97.87% |
Hyster-Yale Materials Handling (HY) | 1/1/2023 - 3/31/2023 | 96.68% |
D-MARKET Electronic Services & Trading ADR (HEPS) | 1/1/2023 - 3/31/2023 | 95.34% |
ThredUp (TDUP) | 1/1/2023 - 3/31/2023 | 90.23% |
